Protein kinase inhibitors

Cambridge Bioscience offers more than 1,300 selective and non-selective kinase inhibitors from Cayman Chemical, used to modulate and target specific nodes of the major kinase-dependent signalling pathways.

Ideal for research to understand kinase mechanics that influence normal and malignant states, these protein kinase inhibitors can be applied for research in degenerative, metabolic, cardiovascular, and infectious diseases.